These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26780991)

  • 1. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.
    Qiu L; Wang DR; Zhang XY; Gao S; Li XX; Sun GP; Lu XB
    Transfus Apher Sci; 2016 Apr; 54(2):235-41. PubMed ID: 26780991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival.
    Kwon AH; Matsui Y; Kamiyama Y
    Cancer; 2001 Feb; 91(4):771-8. PubMed ID: 11241245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of perioperative blood transfusion on the prognosis in hereditary and sporadic colon cancer.
    Li XX; Meng J; Sun GP; Tang YX; Liang GF; Wang MF; Lu XB
    Biomarkers; 2015; 20(6-7):481-6. PubMed ID: 26616149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer.
    De Oliveira GS; Schink JC; Buoy C; Ahmad S; Fitzgerald PC; McCarthy RJ
    Transfus Med; 2012 Apr; 22(2):97-103. PubMed ID: 22151920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subsets, natural killer cytotoxicity, and perioperative blood transfusion for elective colorectal cancer surgery.
    Tartter PI; Martinelli G
    Cancer Detect Prev Suppl; 1987; 1():571-6. PubMed ID: 3480069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma.
    Gong Y; Tang Y; Xue Y; Chen L
    Medicine (Baltimore); 2020 Oct; 99(41):e22568. PubMed ID: 33031305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
    Heiss MM; Mempel W; Delanoff C; Jauch KW; Gabka C; Mempel M; Dieterich HJ; Eissner HJ; Schildberg FW
    J Clin Oncol; 1994 Sep; 12(9):1859-67. PubMed ID: 8083709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
    Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ
    Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence.
    van de Watering LM; Brand A; Houbiers JG; Klein Kranenbarg WM; Hermans J; van de Velde C;
    Br J Surg; 2001 Feb; 88(2):267-72. PubMed ID: 11167879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of perioperative allogeneic blood transfusion on survival in elderly patients with colorectal cancer.
    Kaneko M; Sasaki S; Ishimaru K; Terai E; Nakayama H; Watanabe T
    Anticancer Res; 2015 Jun; 35(6):3553-8. PubMed ID: 26026124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
    Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
    Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.
    Chen G; Zhang FJ; Gong M; Yan M
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):560-5. PubMed ID: 17657857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.
    Jahnson S; Andersson M
    Eur J Surg; 1992 Aug; 158(8):419-25. PubMed ID: 1356481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer.
    Miki C; Hiro J; Ojima E; Inoue Y; Mohri Y; Kusunoki M
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):60-6. PubMed ID: 16477921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases.
    Schiergens TS; Rentsch M; Kasparek MS; Frenes K; Jauch KW; Thasler WE
    Dis Colon Rectum; 2015 Jan; 58(1):74-82. PubMed ID: 25489697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of allogeneic blood transfusion in patients with stage II colon cancer.
    Meng J; Lu XB; Tang YX; Sun GP; Li X; Yan YF; Liang GF; Ma SP; Li XX
    Asian Pac J Cancer Prev; 2013; 14(1):347-50. PubMed ID: 23534751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival.
    Ghinea R; Greenberg R; White I; Sacham-Shmueli E; Mahagna H; Avital S
    Tech Coloproctol; 2013 Oct; 17(5):549-54. PubMed ID: 23605190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of perioperative allogenic blood transfusion on prognosis of colorectal cancer].
    Zimmermann T; Dobroschke J; Borowek U; Padberg W
    Zentralbl Chir; 1991; 116(19):1125-38. PubMed ID: 1759510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.
    Houbiers JG; Brand A; van de Watering LM; Hermans J; Verwey PJ; Bijnen AB; Pahlplatz P; Eeftinck Schattenkerk M; Wobbes T; de Vries JE
    Lancet; 1994 Aug; 344(8922):573-8. PubMed ID: 7914960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.